High Dose Ascorbic Acid for Plasma Cell Disorders

NCT03602235 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

OTHER: Ascorbate
DRUG: Melphalan

Sponsor

Christopher Strouse

Collaborators

[object Object]